We describe a sensitive, precise high-pressure liquid chromatographic method in which 5-(p-methylphenyl)-5-phenyihydantoinisused as the internal standardforsimultaneous determination of diphenyihydantoin, phenobarbital, and primidone in whole blood and plasma. These anticonvulsant drugs are well separated from each other and from normal blood constituents in less than 10 mm. The lower limit of detection for each drug is 100 ng for primidone, 200 ng for dilantin, and 300 ng for phenobarbital. The eluted drugs were detected by their absorption at 254 nm, and evaluated from their peak heights as compared to internal standard. The method was successfully adapted for pediatric samples (100 to 500 Jl of whole blood or plasma). Fifty specimens were analyzed for phenobarbital and diphenylhydantoin and 25 specimens for primidone by a standard gas-chromatographic method and by our liquid-chromatographic method; the resulting correlation coefficient was >0.98.
at 254 nm, and evaluated from their peak heights as compared to internal standard. The method was successfully adapted for pediatric samples (100 to 500 Jl of whole blood or plasma). Fifty specimens were analyzed for phenobarbital and diphenylhydantoin and 25 specimens for primidone by a standard gas-chromatographic method and by our liquid-chromatographic method; the resulting correlation coefficient was >0.98. However, the method required a multi-step sample preparation procedure with critical pH adjustments, and no provision was made for use of an internal standard. While our studies were in progress, two additional methods were reported for the analysis of anticonvulsants by highpressure liquid chromatography (9, 10). The first method (9) measures the concentration of phenobarbital and diphenylhydantoin in serum, but no provision was made to determine primidone concentration. The second method (10) measures the concentration of several anticonvulsants in serum. However, the authors reported recovery rates for the drugs of only 40-73% from serum, with use of the charcoal-adsorption technique. Their detection of column effluent at 195 nm is fairly nonspecific, and the method is not adaptable with instruments equipped with a fixed-wavelength ultraviolet detector. Their use of phenacetin, a commonly used analgesic drug, as an internal standard is a potential source of error in the quantitation of these drugs. In contrast to the above methods, our method offers: (a) rapid, sensitive, and simultaneous assay of diphenylhydantoin, phenobarbital, and primidone in small volumes of whole blood or plasma; (b) rapid, quantitative, single-step solvent extraction of these drugs from whole blood and plasma; and (c) easy adaptation of the method to determination of these drugs in pediatric samples (100-500 zl of blood or plasma). Values for 825 whole blood or plasma from the same subject on anticonvulsant therapy did not differ significantly; hence the method could be used interchangeably for either. Total chromatographic time is less than 10 mm.
Materials and Methods

Chromatography
We used a Model 601 (Perkin-Elmer Corp., Norwalk, 
Results
Figure 1 shows representative chromatograms of the drug reference standard and whole blood extracted specimens. Figure 1A shows a typical chromatogram for the drug reference standard, Figure 113a chromatogram from whole blood of a patient receiving all three of these drugs. Primidone, diphenylhydantoin, and phenobarbital could each be quantitated at a concentration of 1 mg/liter-far below the therapeutic range.
Linearity:
Whole 
Comparison between Whole Blood and Plasma
Whole blood and plasma specimens from patients on anticonvulsant therapy were processed and drug con- Comparison between Micro-Scale and Regular Samples Micro-scale samples (100 to 500 tl) of whole blood or plasma from patients on these drugs were assayed and compared with regular (2 ml) samples (Table 3) . We could easily detect 2 mg/liter of these drugs when only 100 1 of sample was used.
Quantitation and Identification of the Drugs
Quantitation was done by measuring the peak heights of the drugs relative to the internal standard. The drugs were identified by retention time. Effluent corresponding to several of the resulting peaks for each drug was collected and subjected to chemical ionization mass-spectroscopy.
The mass spectrum of each was identical with that of the authentic drug. Interference from Other Drugs
To determine the potential usefulness of the procedure, we checked for possible interference from several other drugs by chromatographing pure standards and physiological samples. Table 4 shows the retention times for the drugs tested.
Comparison
with Gas Chromatography Table 5 presents the comparison data for the assay of these three drugs by our procedure and by a gas chromatographic method.
